Clinical Trial: Investigation of the Molecular Mechanisms Underlying Therapeutic Resistance and Precision Medicine Strategies in Epithelial Ovarian Cancer (China)

Posted On: 2026-11-04

China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Investigation of the Molecular Mechanisms Underlying Therapeutic Resistance and Precision Medicine Strategies in Epithelial Ovarian Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135921

Registration Time: 2026/11/03

Type: Observational study

Primary Sponsor: Cancer Hospital Chinese Academy of Medical Sciences

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=329749

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Investigation of the Molecular Mechanisms Underlying Therapeutic Resistance and Precision Medicine Strategies in Epithelial Ovarian Cancer (China)